Report Highlights
The global market for medical membrane devices should grow from $28.6 billion in 2018 to $36.5 billion by 2023 at a compound annual growth rate (CAGR) of 5.0% for the period of 2018-2023.
Report Includes
- 21 data tables and 18 additional tables
- Detailed overview and an in-depth analysis of the medical membrane device industry structure
- Analyses of global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Information on the present and future strategies within the different medical membrane devices market including hemodialyzers, membrane oxygenators, intravenous infusion (IV) filters, blood microfilters, apheresis systems and membrane diagnostic devices
- Segmentation of the global medical membrane device technologies market by technology type, end use, application industry and geographical region
- Technological assessment of the use of medical membrane devices for cardiopulmonary treatments, renal diseases, parenteral administration and home-care diagnosis
- Discussion of the impact of device applications and trends, pricing considerations, research and development activities and environmental influences, along with the performance of the market in terms of setbacks and the needs
- A frame for membrane components of each sector in context with the market dynamics of the overall technology
- Coverage of the latest significant patents by type of device, by company and other categorizations
- Profiles of major companies in the field along with a competitive technology analysis including 3M, Abbott Laboratories, Baxter International Inc., LifeScan Inc. and Toray Industries Inc.
Report Scope
The scope of this report encompasses key market analysis, market drivers, market constraints and also competitive developments and trends in the market. BCC Research analyzes each market and its applications, regulatory environment, technology, market projections and market shares. This report involves the medical membrane devices used in the medical device industry. This report mainly deals with the medical membrane devices market covering the total market, which includes hemodialyzers, membrane oxygenators, intravenous infusion (IV) infusion filters, blood microfilters and apheresis systems, and membrane diagnostic devices. The report also covers the use of medical membrane devices for cardiopulmonary treatments, renal diseases, parenteral administration and home care diagnosis. It also covers details regarding healthcare spending and the U.S. healthcare system.
Excluded from this report are membranes employed in other facets of medicine. These applications and devices include hollow fiber bioreactors employed in the production of monoclonal antibodies, recombinant proteins and drugs, nonseparating membranes used in drug-delivery systems, tissue scaffolding and synthetic skin. In addition, experimental artificial organs (e.g., liver, pancreas, implanted lung); apheresis filtration for stem cell recovery, virus filters and other cross-flow filters used in the production of pharmaceuticals; and blotting membranes (excluding their application in diagnostics) will not be considered in this report.
Analyst Credentials
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
Report Highlights
Global revenue for medical membrane devices was valued at $25.2 billion in 2013 and $25.6 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 2.3% from 2015 through 2020; reach $26.3 billion by 2015 and $29.4 billion by 2020.
Report Includes
- An overview of the global markets and technologies for medical membrane devices.
- Analyses of global market trends, with data from 2013 and 2014, estimates for 2015, and projections of CAGRs through 2020.
- Analysis of the relevant technical and economic drivers for the medical membrane device market by technology type.
- Information on the impact of device applications and trends, pricing considerations, research and development (R&D), and environmental influences.
- Evaluation of the industry structure.
- Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
- A frame for membrane components of each sector in context with the market dynamics of the overall technology.
- Profiles of major companies in the field along with a competitive technology analysis.
Report Highlights
The U.S. medical membrane device market was valued at $2.1 billion in 2010 and is expected to be nearly $2.2 billion by the end of 2011. This market is forecast to grow to $2.9 billion by 2016, a compound annual growth rate (CAGR) of 5%.
Report Highlights
- The medical membrane device market, which includes dialyzers, blood oxygenators, IV filters and blood/apheresis filters, is valued at nearly $2 billion in 2009 and is expected to increase at a compound annual growth rate (CAGR) of 4.6% through 2014
- Sales of dialyzers and blood oxygenators and IV filters are primarily market-driven, while sales of blood/apheresis filters and diagnostic devices are principally technology-driven
- Sales of diagnostic devices continue to skyrocket. Applauded by managed care, a growing number of point-of-care (POC) and home tests are available for a host of new and existing applications.
Report Highlights
-
The medical membrane device market, including dialyzers, blood oxygenators, IV filters and blood/apheresis filters, is valued at nearly $1.8 billion in 2007 and is increasing at a compound annual growth rate (CAGR) of 5.3% to reach $ 2.3 billion in 2012.
-
The combined worth of market-driven devices is about $623 million, rising at a compound annual growth rate of 3.6%. More than 235,000 U.S. kidney patients require dialysis on an ongoing basis to maintain renal function. Growth in the hemodialyzer market is driven by an increasing patient population, the phaseout of reusable dialyzers and the discovery that nonmembrane home dialysis may be applicable to a broader target audience
-
Technology driven products, such as blood/apheresis microfilters and diagnostic devices, have a combined value of $1.1 billion, with a 6.2% CAGR. Sales of these products for the most part, are spurred by improvements in design and materials, and by new applications.
Report Highlights
-
The U.S. medical membrane device market is valued at $1.7 billion in 2001.
-
Increasing at an average annual growth rate (AAGR) of 7.1%, this market is expected to reach nearly $2.5 billion in 2006.
-
Sales of dialyzers and blood oxygenators, and increasingly leukofilters, are primarily market driven and are valued at $883 million in 2001 and growing at an AAGR 8.1%.
-
Sales of IV filters, blood/apheresis filters and diagnostic devices are principally technology driven and have a combined value of $859 million, with a 5.9% AAGR.
-
Sales of diagnostic devices have skyrocketed, driven by managed care, point-of-care and home tests for a host of applications.
Related Reports
Major Reverse Osmosis System Components for Water Treatment: The Global Market
The global market for RO system components is expected to grow from $18.8 billion in 2024 and is projected to reach $32.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.
Global Markets and Technologies for Nanofiltration
The global market for nanofiltration is expected to grow from $1.5 billion in 2024 and is projected to reach $3.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% during the forecast period of 2024 to 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Ultrafiltration Membranes: Technologies and Global Markets
The global market for ultrafiltration membranes was valued at $4.9 billion in 2023. The market is expected to grow from $5.2 billion in 2024 to $8.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2029.
Recent Reports
Major Reverse Osmosis System Components for Water Treatment: The Global Market
The global market for RO system components is expected to grow from $18.8 billion in 2024 and is projected to reach $32.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.
Ultrafiltration Membranes: Technologies and Global Markets
The global market for ultrafiltration membranes was valued at $4.9 billion in 2023. The market is expected to grow from $5.2 billion in 2024 to $8.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2029.
Pharmaceutical Filtration: Global Markets
The global market for pharmaceutical filtration was valued at $10.4 billion in 2023. The market is estimated to grow from $11.4 billion in 2024 to $18.1 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2029.
Water Filtration: Global Markets
The global market for water filtration is expected to grow from $10.5 billion in 2024 and is projected to reach $19.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2029.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $17.4 billion in 2023 to reach $25.7 billion by 2028, at a compound annual growth rate (CAGR) of 8.1% from 2023 through 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More